Näytä suppeat kuvailutiedot

dc.contributor.authorSelenius, Jannica S.
dc.contributor.authorSilveira, Patricia P.
dc.contributor.authorBonsdorff, Mikaela von
dc.contributor.authorLahti, Jari
dc.contributor.authorKoistinen, Hannu
dc.contributor.authorKoistinen, Riitta
dc.contributor.authorSeppälä, Markku
dc.contributor.authorEriksson, Johan G.
dc.contributor.authorWasenius, Niko S.
dc.date.accessioned2024-04-29T05:02:11Z
dc.date.available2024-04-29T05:02:11Z
dc.date.issued2024
dc.identifier.citationSelenius, J. S., Silveira, P. P., Bonsdorff, M. V., Lahti, J., Koistinen, H., Koistinen, R., Seppälä, M., Eriksson, J. G., & Wasenius, N. S. (2024). Biologically Informed Polygenic Scores for Brain Insulin Receptor Network Are Associated with Cardiometabolic Risk Markers and Diabetes in Women. <i>Diabetes & Metabolism Journal</i>, <i>Early online</i>. <a href="https://doi.org/10.4093/dmj.2023.0039" target="_blank">https://doi.org/10.4093/dmj.2023.0039</a>
dc.identifier.otherCONVID_213337778
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/94530
dc.description.abstractBackground To investigate associations between variations in the co-expression-based brain insulin receptor polygenic score and cardiometabolic risk factors and diabetes mellitus. Methods This cross-sectional study included 1,573 participants from the Helsinki Birth Cohort Study. Biologically informed expression-based polygenic risk scores for the insulin receptor gene network were calculated for the hippocampal (hePRS-IR) and the mesocorticolimbic (mePRS-IR) regions. Cardiometabolic markers included body composition, waist circumference, circulating lipids, insulin-like growth factor 1 (IGF-1), and insulin-like growth factor-binding protein 1 and 3 (IGFBP-1 and -3). Glucose and insulin levels were measured during a standardized 2-hour 75 g oral glucose tolerance test and impaired glucose regulation status was defined by the World Health Organization 2019 criteria. Analyzes were adjusted for population stratification, age, smoking, alcohol consumption, socioeconomic status, chronic diseases, birth weight, and leisure-time physical activity. Results Multinomial logistic regression indicated that one standard deviation increase in hePRS-IR was associated with increased risk of diabetes mellitus in all participants (adjusted relative risk ratio, 1.17; 95% confidence interval, 1.01 to 1.35). In women, higher hePRS-IR was associated with greater waist circumference and higher body fat percentage, levels of glucose, insulin, total cholesterol, low-density lipoprotein cholesterol, triglycerides, apolipoprotein B, insulin, and IGFBP-1 (all P≤0.02). The mePRS-IR was associated with decreased IGF-1 level in women (P=0.02). No associations were detected in men and studied outcomes. Conclusion hePRS-IR is associated with sex-specific differences in cardiometabolic risk factor profiles including impaired glucose regulation, abnormal metabolic markers, and unfavorable body composition in women.en
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherKorean Diabetes Association
dc.relation.ispartofseriesDiabetes & Metabolism Journal
dc.rightsCC BY-NC 4.0
dc.subject.othercardiometabolic risk factors
dc.subject.otherdiabetes mellitus
dc.subject.otherlipid metabolism
dc.titleBiologically Informed Polygenic Scores for Brain Insulin Receptor Network Are Associated with Cardiometabolic Risk Markers and Diabetes in Women
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-202404293158
dc.contributor.laitosLiikuntatieteellinen tiedekuntafi
dc.contributor.laitosFaculty of Sport and Health Sciencesen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.description.reviewstatuspeerReviewed
dc.relation.issn2233-6079
dc.relation.volumeEarly online
dc.type.versionpublishedVersion
dc.rights.copyright© 2024 Korean Diabetes Association
dc.rights.accesslevelopenAccessfi
dc.subject.ysodiabetes
dc.subject.ysorasva-aineenvaihdunta
dc.subject.ysokehonkoostumus
dc.subject.ysosukupuolierot
dc.subject.ysobiomarkkerit
dc.subject.ysoriskitekijät
dc.subject.ysosydän- ja verisuonitaudit
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p8304
jyx.subject.urihttp://www.yso.fi/onto/yso/p38464
jyx.subject.urihttp://www.yso.fi/onto/yso/p26989
jyx.subject.urihttp://www.yso.fi/onto/yso/p5290
jyx.subject.urihttp://www.yso.fi/onto/yso/p12288
jyx.subject.urihttp://www.yso.fi/onto/yso/p13277
jyx.subject.urihttp://www.yso.fi/onto/yso/p9886
dc.rights.urlhttps://creativecommons.org/licenses/by-nc/4.0/
dc.relation.doi10.4093/dmj.2023.0039
jyx.fundinginformationThis study was supported by the Finnish Foundation for Cardiovascular Research, Finnish Foundation for Diabetes Research, Juho Vainio Foundation, Academy of Finland, Novo Nordisk Foundation, Signe and Ane Gyllenberg Foundation, Samfundet Folkhälsan, Finska Läkaresällskapet, Liv och Hälsa, European Commission FP7 (DORIAN) Grant Agreement No. 278603 and EU H2020-PHC-2014-DynaHealth Grant No. 633595 and EU Horizon 2020 Award 733206 LIFECYCLE. Patricia P. Silveira is supported by Canadian Institutes of Health Research (CIHR, PJT-166066, PI Patricia P. Silveira). Hannu Koistinen is supported by Sigrid Jusélius Foundation.
dc.type.okmA1


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot

CC BY-NC 4.0
Ellei muuten mainita, aineiston lisenssi on CC BY-NC 4.0